Tin tức & Cập nhật

Bladder cancer survivors who do not smoke enjoy better life quality
Bladder cancer survivors who do not smoke enjoy better life quality
04 Jul 2024

Among patients with bladder cancer (BC), those who do not smoke appear to have better longitudinal health-related quality of life (HRQoL) measures, particularly in the domains of physical function, emotional function, and fatigue, according to a recent study.

Bladder cancer survivors who do not smoke enjoy better life quality
04 Jul 2024
Intense exercise safe for men with metastatic prostate cancer
Intense exercise safe for men with metastatic prostate cancer
13 Jun 2024 bởiStephen Padilla

Patients with metastatic prostate cancer can safely engage in intense exercise training to improve survival outcomes, suggests a study presented at AACR 2024.

Intense exercise safe for men with metastatic prostate cancer
13 Jun 2024
ART discontinuation tied to toxicity, disease progression in mCRPC patients
ART discontinuation tied to toxicity, disease progression in mCRPC patients
07 Jun 2024

Several patients with metastatic castration-resistant prostate cancer (mCRPC) discontinue the use of androgen receptor‒targeted therapies (ARTs) because of disease progression, while a few stopped ARTs due to treatment toxicity, according to a study.

ART discontinuation tied to toxicity, disease progression in mCRPC patients
07 Jun 2024
More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
09 May 2024 bởiKanas Chan

Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide reported more fatigue, depression and deterioration in perceived cognitive ability, and slower reaction time than those receiving abiraterone acetate, according to results of the ACE study.

More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
09 May 2024